Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond H Kim

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Human Genetics|June 23, 2022
A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findingsJordan Sam, Emma Reble, Rita Kodida, et al.
BMJ Open|August 10, 2025
TRIAGE-GS: protocol for a randomised controlled trial of a genomics-first approach to rare disease diagnosis for patients awaiting assessment by a clinical geneticistKaitlin J Stanley, Caitlin Chisholm, Meredith K Gillespie, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 11, 2020
The Cardiac Genome Clinic: implementing genome sequencing in pediatric heart diseaseMiriam S Reuter, Rajiv R Chaturvedi, Eriskay Liston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>Adriana I Apostol, Jacek Gronwald, Cezary Cybulski, et al.
Journal of Medical Genetics|May 22, 2023
A model for the return and referral of all clinically significant secondary findings of genomic sequencingRita Kodida, Emma Reble, Marc Clausen, et al.
Frontiers in Genetics|October 28, 2020
Genes and Pathways Implicated in Tetralogy of Fallot Revealed by Ultra-Rare Variant Burden Analysis in 231 Genome SequencesRoozbeh Manshaei, Daniele Merico, Miriam S Reuter, et al.
Journal of Medical Genetics|July 26, 2018
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmapJeanna M McCuaig, Tracy L Stockley, Patricia Shaw, et al.
Journal of the National Cancer Institute|December 17, 2025
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2Joanne Kotsopoulos, Marta Seca, Jacek Gronwald, et al.
Human Mutation|April 27, 2022
Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau diseaseAndreea Chiorean, Kirsten M Farncombe, Sean Delong, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Human Genetics|June 23, 2022
A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findingsJordan Sam, Emma Reble, Rita Kodida, et al.
BMJ Open|August 10, 2025
TRIAGE-GS: protocol for a randomised controlled trial of a genomics-first approach to rare disease diagnosis for patients awaiting assessment by a clinical geneticistKaitlin J Stanley, Caitlin Chisholm, Meredith K Gillespie, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 11, 2020
The Cardiac Genome Clinic: implementing genome sequencing in pediatric heart diseaseMiriam S Reuter, Rajiv R Chaturvedi, Eriskay Liston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>Adriana I Apostol, Jacek Gronwald, Cezary Cybulski, et al.
Journal of Medical Genetics|May 22, 2023
A model for the return and referral of all clinically significant secondary findings of genomic sequencingRita Kodida, Emma Reble, Marc Clausen, et al.
Frontiers in Genetics|October 28, 2020
Genes and Pathways Implicated in Tetralogy of Fallot Revealed by Ultra-Rare Variant Burden Analysis in 231 Genome SequencesRoozbeh Manshaei, Daniele Merico, Miriam S Reuter, et al.
Journal of Medical Genetics|July 26, 2018
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmapJeanna M McCuaig, Tracy L Stockley, Patricia Shaw, et al.
Journal of the National Cancer Institute|December 17, 2025
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2Joanne Kotsopoulos, Marta Seca, Jacek Gronwald, et al.
Human Mutation|April 27, 2022
Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau diseaseAndreea Chiorean, Kirsten M Farncombe, Sean Delong, et al.
Pageof 20